[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

Gasparini et al., 1992 - Google Patents

Pharmacokinetics of doxorubicin loaded and glutaraldehyde treated erythrocytes in healthy and lymphoma bearing dogs

Gasparini et al., 1992

Document ID
13919126595552384827
Author
Gasparini A
Tonetti M
Astroff B
Rowe L
Satterfield W
Schmidt R
DeLoach J
Publication year
Publication venue
The Use of Resealed Erythrocytes as Carriers and Bioreactors

External Links

Snippet

Doxorubicin, an anthracycline aminoglycoside, is a potent antineoplastic agent with a wide spectrum of activity against human malignancies such as breast and bladder carcinomas, sarcomas, and lymphomas. 1, 2 Its therapeutic potential is limited by hematopoietic and …
Continue reading at link.springer.com (other versions)

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A61K9/0024—Solid, semi-solid or solidifying implants, which are implanted or injected in body tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives
    • A61K47/48—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates
    • A61K47/48169—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers, inert additives the non-active ingredient being chemically bound to the active ingredient, e.g. polymer drug conjugates the modifying agent being an organic macromolecular compound, i.e. an oligomeric, polymeric, dendrimeric molecule
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
    • A61K41/00—Medicinal preparations obtained by treating materials with wave energy or particle radiation; Therapies using these preparations

Similar Documents

Publication Publication Date Title
Takakura et al. Disposition and tumor localization of mitomycin C–dextran conjugates in mice
Deaciuc et al. Modulation of hepatic sinusoidal endothelial cell function by Kupffer cells: an example of intercellular communication in the liver
KR100371826B1 (en) Parenteral administration plate for the treatment of malignant disease
Kravtzoff et al. Improved pharmacodynamics of L-asparaginase-loaded in human red blood cells
JPS58183625A (en) Enzyme transfer system
CN113750244A (en) Engineered platelet carrying chemotherapeutic drug and containing external back immune checkpoint inhibitor nanogel as well as preparation method and application of engineered platelet
Zhang et al. Hypoxia-responsive nanogel as IL-12 carrier for anti-cancer therapy
Ni et al. Tumor microenvironment-responsive nanodrug for clear-cell renal cell carcinoma therapy via triggering waterfall-like cascade ferroptosis
Ravilla et al. Erythrocytes as carrier for drugs, enzymes and peptides
US4868158A (en) Method for the production of a macromolecular carrier loaded with a biologically active substance
CN114699537B (en) ROS response anticancer drug for improving curative effect of hypoxia-sensitized PD-1 antibody
Gasparini et al. Pharmacokinetics of doxorubicin loaded and glutaraldehyde treated erythrocytes in healthy and lymphoma bearing dogs
Hoshi et al. Internal iliac arterial infusion chemotherapy for rabbit invasive bladder cancer
Tonetti et al. Use of glutaraldehyde treated autologous human erythrocytes for hepatic targeting of doxorubicin
Tonetti et al. Pharmacokinetic properties of doxorubicin encapsulated in glutaraldehyde-treated canine erythrocytes
Alvarez et al. In vivo survival and organ uptake of loaded carrier rat erythrocytes
Kerr et al. Target organ disposition and plasma pharmacokinetics of doxorubicin incorporated into albumin microspheres after intrarenal arterial administration
EP3228327A2 (en) Substance and method for using the substance mentioned for modulating the activity of an agent in an organism
CN116549404A (en) mRNA lipid nanoparticle freeze-dried preparation containing stabilizer and preparation method thereof
Jangde An Overview of resealed erythrocyte for cancer therapy
MUNECHIKA et al. Tissue distribution of macromolecular conjugate, adriamycin linked to oxidized dextran, in rat and mouse bearing tumor cells
DeLoach Encapsulation potential of a trypanocidal drug homidium bromide in bovine carrier erythrocytes
Sur et al. Response of methylenetetrahydrofolate levels to methotrexate in Krebs ascites cells
Newman et al. A Phase I study of the combined hypoxic cell radiosensitisers, Ro 03–8799 and SR 2508: a preliminary report of single-dose toxicity, pharmacokinetics and tumour concentrations
Liu et al. Immunoliposome targeting to pulmonary endothelium